Approach to diagnosis of Parkinson disease

Canadian Family Physician

Volumn 52, Issue 7, 2006, Pages 862-868

  Frank, Christopher ^a,b   Pari, Giovanna ^a,c   Rossiter, John P ^a,c  

^a QUEEN S UNIVERSITY   (Canada)

^b St Mary's of the Lake Hospital   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CARBIDOPA PLUS LEVODOPA; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PROCHLORPERAZINE; RISPERIDONE;

ACCURACY; AGING; AKINESIA; BODY POSTURE; CLINICAL FEATURE; CONSENSUS; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; FACIAL EXPRESSION; FRAIL ELDERLY; GAIT DISORDER; HUMAN; MEDLINE; PARKINSON DISEASE; PARKINSONISM; PREVALENCE; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RIGIDITY; SHY DRAGER SYNDROME; TREMOR;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; GERIATRIC ASSESSMENT; HUMANS; MALE; PARKINSON DISEASE; PARKINSONIAN DISORDERS;

EID: 33748790415     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Rao G, Fisch L, Srinivasan S, D'Amico F, Okada T, Eaton C, et al. Does this patient have Parkinson disease? JAMA 2003;289(3):347-53.
2. De Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63(7):1240-4.
3. De Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al. Prevalence of Parkinson's disease in Europe. A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11 Suppl 5):S21-3.
4. Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. SAGE Study Group. Pharmacotherapy 1999;19(11):1321-7.
5. Larsen JP. Parkinson's disease as a community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly. BMJ 1991;303(6805):741-3.
6. Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996;44(4):394-9.
7. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42(6):1142-6.
8. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50(2):140-8.
9. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol 1993;60:595-9.
10. Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002;73(5):529-34.
11. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(Suppl 1):S125-7.
12. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56(1):33-9.
13. Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004;11(5):315-20.
14. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996;53(2):175-9.
15. Nagayama H, Hamamoto M, Nito C, Takagi S, Miyazaki T, Katayama Y. Initial symptoms of Parkinson's disease with elderly onset. Gerontology 2000;46(3):129-32.
16. Brodsky H, Dat VK, Thomas M, Jankovic J. Glabellar and palmomental reflexes in Parkinsonian disorders. Neurology 2004;63(6):1096-8.
17. Katzenschlager R, Lees AJ. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004;17(4):417-23.
18. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-9.
19. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1783-93.
20. Clarke CE, Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69(5):590-4.
21. Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19(6):630-40.
22. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 1998;74(2-3):189-92.
23. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, et al. [Consensus on the diagnosis of multi-system atrophy]. Neurologia 1999;14(9):425-8.
24. Litvan I, Agid Y, Calne D, Campbell B, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47(1):1-9.
25. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18(5):467-86.
26. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson EW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47(5):1113-24.
27. Hassin-Baer S, Sirota P, Korczyn AD, Treves TA, Epstein B, Shabtai H, et al. Clinical characteristics of neuroleptic-induced Parkinsonism. J Neural Transm 2001;108(11):1299-308.
28. Tolosa E, Valldeoriola F, Marti MJ. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Suppl 1994;42:15-31.
29. Kish SJ, Shannak K, Rajput A, Deck JH, Homykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 1992;58(2):642-8.
30. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. Using antipsychotic agents in older patients. J Clin Psychiatry 2004;65(Suppl 2):5-99.
31. Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther 2001;23(11):1839-54.
32. Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, et al. Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 2002;13(3):183-92.